FGF23 and chronic kidney disease: Moreover, pharmacological blockage of FGF23 using specific anti-FGF23 antibodies [15] and short-acting small molecules reversibly inhibiting FGF23 [30,32] prevent cardiac and immune effects in vitro and in CKD mice.